The pharmaceutical firm was among the investors in a series G round that valued precision medicine technology provider Tempus at $5bn.

Microsoft, PayU, Boston Consulting Group, CMT Digital and founding investor Intercontinental Exchange all backed the digital wallet provider's series B round.

Wipro Ventures exited email security software developer Emailage, when it was acquired by LexisNexis Risk Solutions. The sizeable deal is part of the wider cybersecurity space which has been popular over recent years.

The Tencent, Bank Central Asia and Mastercard-backed cross-border remittance service is seeking series D funding and is in talks with an unnamed financial services firm to lead the round.

The LinkedIn-backed data streaming platform developer is in talks with investors for a $200m to $300m round that could double its valuation to $5bn.

The immunotherapy developer, which counts Pfizer, Sanofi, Merck & Co, Eli Lilly, Amgen and Vertex Pharmaceuticals as early investors, has picked up $102m.

The ultrasound surgery system developer is targeting $150m at a $1.3bn post-money valuation, with Koch Disruptive Technologies supplying $100m.

Uday Kumar, whose previous spinout iRhythm is trading with a market cap of $2.6bn, has collected $145.6m in a GV-backed round for his latest venture.

The wearable defibrillator developer, founded by Stanford adjunct professor Uday Kumar, has raised more than $145m that will support the launch of its lead product.

Pliant Therapeutics has attracted $100m in a series C round led by Novartis, four years after it was founded to commercialise UC San Francisco research into fibrosis treatment.